159 related articles for article (PubMed ID: 28139275)
21. A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor.
Blaschke F; Takata Y; Caglayan E; Collins A; Tontonoz P; Hsueh WA; Tangirala RK
Circ Res; 2006 Dec; 99(12):e88-99. PubMed ID: 17110595
[TBL] [Abstract][Full Text] [Related]
22. Hyperoside Inhibits RNF8-mediated Nuclear Translocation of β-catenin to Repress PD-L1 Expression and Prostate Cancer.
Chen J; Zhao Y; Wang X; Zang L; Yin D; Tan S
Anticancer Agents Med Chem; 2024; 24(6):464-476. PubMed ID: 38305391
[TBL] [Abstract][Full Text] [Related]
23. Estrogen receptor beta (ERβ) mediates expression of β-catenin and proliferation in prostate cancer cell line PC-3.
Lombardi AP; Pisolato R; Vicente CM; Lazari MF; Lucas TF; Porto CS
Mol Cell Endocrinol; 2016 Jul; 430():12-24. PubMed ID: 27107935
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of fatty acid synthase (FASN) affects the proliferation and apoptosis of HepG2 hepatoma carcinoma cells via the β-catenin/C-myc signaling pathway.
Zhang W; Huang J; Tang Y; Yang Y; Hu H
Ann Hepatol; 2020; 19(4):411-416. PubMed ID: 32536483
[TBL] [Abstract][Full Text] [Related]
25. Activation of the Liver X Receptor Pathway Inhibits HBV Replication in Primary Human Hepatocytes.
Zeng J; Wu D; Hu H; Young JAT; Yan Z; Gao L
Hepatology; 2020 Dec; 72(6):1935-1948. PubMed ID: 32145089
[TBL] [Abstract][Full Text] [Related]
26. Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells.
Pommier AJ; Alves G; Viennois E; Bernard S; Communal Y; Sion B; Marceau G; Damon C; Mouzat K; Caira F; Baron S; Lobaccaro JM
Oncogene; 2010 May; 29(18):2712-23. PubMed ID: 20190811
[TBL] [Abstract][Full Text] [Related]
27. LXR agonist regulates the carcinogenesis of PCa via the SOCS3 pathway.
Fu W; Yao J; Huang Y; Li Q; Li W; Chen Z; He F; Zhou Z; Yan J
Cell Physiol Biochem; 2014; 33(1):195-204. PubMed ID: 24481266
[TBL] [Abstract][Full Text] [Related]
28. LXR activation causes G1/S arrest through inhibiting SKP2 expression in MIN6 pancreatic beta cells.
Li Y; Jing C; Tang X; Chen Y; Han X; Zhu Y
Endocrine; 2016 Sep; 53(3):689-700. PubMed ID: 27071658
[TBL] [Abstract][Full Text] [Related]
29. Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits.
Honzumi S; Shima A; Hiroshima A; Koieyama T; Terasaka N
Biochim Biophys Acta; 2011 Dec; 1811(12):1136-45. PubMed ID: 21875689
[TBL] [Abstract][Full Text] [Related]
30. LXRβ Activation Inhibits the Proliferation of Small-cell Lung Cancer Cells by Depleting Cellular Cholesterol.
Kashiwagi K; Sato-Yazawa H; Ishii J; Kohno K; Tatsuta I; Miyazawa T; Takagi M; Chiba H; Yazawa T
Anticancer Res; 2022 Jun; 42(6):2923-2930. PubMed ID: 35641269
[TBL] [Abstract][Full Text] [Related]
31. MEN1 silencing aggravates tumorigenic potential of AR-independent prostate cancer cells through nuclear translocation and activation of JunD and β-catenin.
Luo Y; Vlaeminck-Guillem V; Baron S; Dallel S; Zhang CX; Le Romancer M
J Exp Clin Cancer Res; 2021 Aug; 40(1):270. PubMed ID: 34446068
[TBL] [Abstract][Full Text] [Related]
32. Palmitic acid-induced apoptosis in pancreatic β-cells is increased by liver X receptor agonist and attenuated by eicosapentaenoate.
Liang H; Zhong Y; Zhou S; Li QQ
In Vivo; 2011; 25(5):711-8. PubMed ID: 21753123
[TBL] [Abstract][Full Text] [Related]
33. VD
Munir MT; Ponce C; Santos JM; Sufian HB; Al-Harrasi A; Gollahon LS; Hussain F; Rahman SM
Mol Biol Rep; 2020 Oct; 47(10):7771-7782. PubMed ID: 32990902
[TBL] [Abstract][Full Text] [Related]
34. TO901317 inhibits the development of hepatocellular carcinoma by LXRα/Glut1 decreasing glycometabolism.
Xiong T; Li Z; Huang X; Lu K; Xie W; Zhou Z; Tu J
Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G598-G607. PubMed ID: 30817182
[TBL] [Abstract][Full Text] [Related]
35. LXR agonism improves TNF-α-induced endothelial dysfunction in the absence of its cholesterol-modulating effects.
Spillmann F; Van Linthout S; Miteva K; Lorenz M; Stangl V; Schultheiss HP; Tschöpe C
Atherosclerosis; 2014 Jan; 232(1):1-9. PubMed ID: 24401210
[TBL] [Abstract][Full Text] [Related]
36. Tumor Suppressor Gene XEDAR Promotes Differentiation and Suppresses Proliferation and Migration of Gastric Cancer Cells Through Upregulating the RELA/LXRα Axis and Deactivating the Wnt/β-Catenin Pathway.
Zhang X; Zhang D; Sun X; Li S; Sun Y; Zhai H
Cell Transplant; 2021; 30():963689721996346. PubMed ID: 33637015
[TBL] [Abstract][Full Text] [Related]
37. LXRα represses LPS-induced inflammatory responses by competing with IRF3 for GRIP1 in Kupffer cells.
Miao CM; He K; Li PZ; Liu ZJ; Zhu XW; Ou ZB; Ruan XZ; Gong JP; Liu CA
Int Immunopharmacol; 2016 Jun; 35():272-279. PubMed ID: 27085678
[TBL] [Abstract][Full Text] [Related]
38. Liver X receptor agonist T0901317 induced liver perturbation in zebrafish: histological, gene set enrichment and expression analyses.
Sukardi H; Zhang X; Lui EY; Ung CY; Mathavan S; Gong Z; Lam SH
Biochim Biophys Acta; 2012 Jan; 1820(1):33-43. PubMed ID: 22047996
[TBL] [Abstract][Full Text] [Related]
39. [Role of beta-catenin signaling pathway in EMT of human prostate cancer induced by HIF-1alpha].
Luo Y; He DL; Jiang YG; Ning L; Shen SL; Zhao JH; Cui XH
Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(16):1131-6. PubMed ID: 20646434
[TBL] [Abstract][Full Text] [Related]
40. Regulation of insulin resistance and adiponectin signaling in adipose tissue by liver X receptor activation highlights a cross-talk with PPARγ.
Zheng F; Zhang S; Lu W; Wu F; Yin X; Yu D; Pan Q; Li H
PLoS One; 2014; 9(6):e101269. PubMed ID: 24972069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
